HARTOUNIAN HARTOUN bought BCLI
February 26, 2026 · Form 4 insider transaction
HARTOUNIAN HARTOUN bought 225,000 shares of Brainstorm Cell Therapeutics Inc. at $0.70 per share, a transaction worth $157.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 83 days after the transaction.
Direction
Acquired (buy-side)
Shares
225,000
Price
$0.70
Total value
$157.5K
InsiderHARTOUNIAN HARTOUN
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMay 20, 2026
Shares owned after225,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.; The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.